Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine guidelines: Rare pancreatic tumors, ultrasound and contrast-enhanced ultrasound features—Malignant mesenchymal tumors-Reference-Cited by-同舟云学术

Comments and illustrations of the European Federation of Societies for Ultrasound in Medicine guidelines: Rare pancreatic tumors, ultrasound and contrast-enhanced ultrasound features—Malignant mesenchymal tumors

Published:2024-03 Issue:2 Volume:13 Page:55-64
ISSN:2226-7190
Container-title:Endoscopic Ultrasound
language:en
Short-container-title:Endosc Ultrasound

Author:

Möller Kathleen¹,Ntovas Sotirios²,Hocke Michael³,On Wei⁴,Everett Simon M.⁴,Braden Barbara⁵,Jenssen Christian,Misselwitz Benjamin²,Ge Nan⁶,Sun Siyu⁶,Gerber Michael¹,Faiss Siegbert¹,Dietrich Christoph F.⁷

Affiliation:

1. Medical Department I/Gastroenterology, Sana Hospital Lichtenberg, Berlin, Germany

2. Department of Visceral Surgery and Medicine, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland

3. Medical Department II, Helios Klinikum Meiningen, Germany

4. Department of Gastroenterology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom

5. Translational Gastroenterology Unit, Oxford University Hospitals, Oxford, United Kingdom

6. Department of Endoscopy Center, Shengjing Hospital of China Medical University, Liaoning Province, China

7. Department Allgemeine Innere Medizin der Kliniken (DAIM) Hirslanden Beau Site, Salem und Permanence, Bern, Switzerland.

Abstract

Abstract Rare malignant mesenchymal pancreatic tumors are systematized and reported in this review. The focus is on the appearance on imaging. The present overview summarizes the data and shows that not every pancreatic tumor corresponds to the most common entities of ductal adenocarcinoma or neuroendocrine tumor.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Reference173 articles.

1. How to perform contrast-enhanced ultrasound (CEUS);Ultrasound Int Open,2018

2. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS;Ultraschall Med,2013

3. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2012: a WFUMB-EFSUMB initiative in cooperation with representatives of AFSUMB, AIUM, ASUM, FLAUS and ICUS;Ultrasound Med Biol,2013

4. Guidelines and good clinical practice recommendations for contrast-enhanced ultrasound (CEUS) in the liver—update 2020 WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS;Ultrasound Med Biol,2020

5. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver—update 2020—WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS;Ultraschall Med,2020